Union Strike Looms At Samsung Bio Amid Massive Revenue Growth
22 Apr 2026 //
FIERCE PHARMA
Samsung Biologics Scores Blbig At 2026 CDMO Leadership Awards
31 Mar 2026 //
INDPHARMAPOST
Samsung Biologics Acquires GSK`s Rockville Pharma Facility
31 Mar 2026 //
PR NEWSWIRE
Samsung Biologics Wins 2026 CDMO Sustainability Award
26 Mar 2026 //
PR NEWSWIRE
Samsung Biologics Labor Union Raises Alarm On Supply Chain Risk
23 Mar 2026 //
PHARMIWEB
Samsung Bio Enhances Climate Transparency With Validated Product
06 Feb 2026 //
PR NEWSWIRE BIO
Samsung to buy US drug production facility from GSK for $280 M
22 Dec 2025 //
REUTERS
Samsung Biologics Joins Pharmaceutical Supply Chain Initiative
06 Aug 2024 //
PR NEWSWIRE
Samsung Biologics Way to reinforce innovative & inclusive organizational culture
19 Jun 2024 //
PRESS RELEASE
Samsung Biologics to attend 2024 BIO International Convention
26 May 2024 //
PRESS RELEASE
Samsung Biologics recognized for service excellence as it receives CDMO Awards
21 Mar 2024 //
PRESS RELEASE
Samsung Biologics hosts 13th Annual General Meeting of Shareholders
15 Mar 2024 //
PRESS RELEASE
Samsung Biologics signs MOU with Seoul National University to foster bio experts
28 Feb 2024 //
PRESS RELEASE
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2023 Financial Results
23 Jan 2024 //
PRESS RELEASE
Samsung eyes expansion; and supply chain diversification
27 Oct 2023 //
ENDPTS
Key Considerations When Selecting an mRNA CDMO Partner
08 Dec 2022 //
PHARMTECH
Seven pharma CEOs announce new joint action to accelerate net zero healthcare
03 Nov 2022 //
BUSINESSWIRE
Samsung Biologics emphasizes speed
02 Nov 2022 //
THEINVESTOR
HHS renews `call to action` with Covid booster ad spots
01 Nov 2022 //
ENDPTS
#CPHI22: As Samsung’s new plant comes online, it looks to expand in Korea
01 Nov 2022 //
ENDPTS
Samsung Biologics Reports Third Quarter 2022 Financial Results
27 Oct 2022 //
PRNEWSWIRE
With $296M deal, GSK expands partnership with Samsung Bio
22 Oct 2022 //
FIERCEPHARMA
Samsung Biologics inks $296 million CMO deal with GSK
20 Oct 2022 //
KOREABIOMED
Samsung Biologics Obtains Two International Information Security Certifications
14 Oct 2022 //
CONTRACTPHARMA
Samsung Biologics obtains three global ISO certifications
13 Oct 2022 //
PRNEWSWIRE
Samsung Biologics unlocks additional capacity for production at newest Plant 4
11 Oct 2022 //
PRNEWSWIRE
Samsung Biologics weighing expansion options outside Korea: CEO
06 Oct 2022 //
FIERCEPHARMA
Samsung Biologics introduces new development platforms S-DUAL and DEVELOPICK
29 Sep 2022 //
PRNEWSWIRE
Samsung Biologics Recognized for its Sustainability Efforts
29 Sep 2022 //
CONTRACTPHARMA
Samsung Biologics Earns Gold Rating from EcoVadis for Its Sustainability Efforts
28 Sep 2022 //
PRNEWSWIRE
AstraZeneca and Samsung ink $350M deal; Michigan CDMO completes expansion
18 Aug 2022 //
B2BCHIEF
GreenLight Biosciences celebrates manufacturing milestone for Covid-19 booster
04 Aug 2022 //
ENDPTS
GreenLight, Samsung Bio`s commercial-scale engineering for mRNA Covid vaccine
01 Aug 2022 //
PRNEWSWIRE
Samsung Biologics Reports Second Quarter 2022 Financial Results
27 Jul 2022 //
PRNEWSWIRE
Samsung’s CDMO arm commits to $324M land purchase for a second bio campus
19 Jul 2022 //
ENDPTS
Samsung Biologics pledges emissions drops in new ESG report
13 Jul 2022 //
ENDPTS
Sustainable CDMO` Samsung Biologics releases 2022 ESG Report
11 Jul 2022 //
PRNEWSWIRE
Samsung Biologics seeks to ramp up biotech funding
16 Jun 2022 //
ENDPTS
GreenLight for mRNA as Samsung Biologics makes first batch
03 Jun 2022 //
BIOPROCESS
Samsung Biologics, AstraZeneca shut down their joint venture Archigen Biotech
24 May 2022 //
KOREAHERALD
Samsung Biologics Reports First Quarter 2022 Financial Results
27 Apr 2022 //
PRNEWSWIRE
Samsung Biologics completes full acquisition of Samsung Bioepis
20 Apr 2022 //
PRNEWSWIRE
Samsung Biologics holds 11th Annual General Meeting of Shareholders
28 Mar 2022 //
PRNEWSWIRE
Biogen sells stake in biosim JV to partner Samsung for $2.3B
29 Jan 2022 //
BIOPHARMADIVE
Samsung will charge forward with `super plant` plans, and look to expand abroad
26 Jan 2022 //
ENDPTS
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2021 Financial Results
24 Jan 2022 //
PRNEWSWIRE
GSK speeds up COVID antibody output amid omicron-fueled demand
21 Jan 2022 //
FIERCEPHARMA
Samsung unit denies report about Biogen buyout talks
31 Dec 2021 //
FIERCEPHARMA
Biogen shares jump on $42 billion Samsung buyout reports
30 Dec 2021 //
FIERCEPHARMA
Samsung Biologics rises as global supply chain for COVID-19 vaccines
27 Dec 2021 //
KOREAHERALD
Samsung Biologics and AstraZeneca expand deal to include Covid-19 treatment
13 Dec 2021 //
PHARMACEUTICAL-TECHNOLOGY
Samsung Biologics, AstraZeneca expand strategic manufacturing partnership
13 Dec 2021 //
PRNEWSWIRE
Moderna Vaccine Manufactured by Samsung Receives Marketing Authorization
13 Dec 2021 //
PRNEWSWIRE
GreenLight Biosciences, Samsung Biologics Partner to Advance New RNA Covid Vax
30 Nov 2021 //
CONTRACTPHARMA
GreenLight and Samsung Biologics collaborate for mRNA Vaccine Manufacturing
24 Nov 2021 //
PRNEWSWIRE
As $2B `superplant` moves ahead, Samsung Biologics touts plans for 5th facility
12 Nov 2021 //
ENDPTS
Samsung Receives FDA Clearance for AI Algorithms for Chest X-rays
28 Oct 2021 //
BIOSPACE
Samsung Biologics Reports Third Quarter 2021 Financial Results
26 Oct 2021 //
PRNEWSWIRE

Market Place
Sourcing Support